| Janis Wiener, MD | |
|
965 Lake St, Oak Park, IL 60301-1292 | |
| (708) 386-3000 | |
| Not Available |
| Full Name | Janis Wiener |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 965 Lake St, Oak Park, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750315586 | NPI | - | NPPES |
| 036081282 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 036081282 (Illinois) | Secondary |
| 207R00000X | Internal Medicine | 036-081282 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola Medicine Home Care | Oak brook, IL | Home health agency |
| Loyola University Medical Center | Maywood, IL | Hospital |
| Macneal Hospital | Berwyn, IL | Hospital |
| Gottlieb Memorial Hospital | Melrose park, IL | Hospital |
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola Medical Group Llc | 6305109547 | 91 |
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
Haitian Prime Minister Jean-Max Bellerive "insisted Tuesday that progress is being made in his devastated homeland despite the trickle of international aid," the Miami Herald reports.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Lampire Biological Laboratories announced today that it signed an agreement with Proliant Health and Biologicals, manufacturer of the worlds most trusted, high quality Bovine Serum Albumin, to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
› Verified 5 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
Haitian Prime Minister Jean-Max Bellerive "insisted Tuesday that progress is being made in his devastated homeland despite the trickle of international aid," the Miami Herald reports.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Lampire Biological Laboratories announced today that it signed an agreement with Proliant Health and Biologicals, manufacturer of the worlds most trusted, high quality Bovine Serum Albumin, to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
› Verified 5 days ago
| Entity Name | Loyola Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376041954 PECOS PAC ID: 6305109547 Enrollment ID: O20180420002063 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
Haitian Prime Minister Jean-Max Bellerive "insisted Tuesday that progress is being made in his devastated homeland despite the trickle of international aid," the Miami Herald reports.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Lampire Biological Laboratories announced today that it signed an agreement with Proliant Health and Biologicals, manufacturer of the worlds most trusted, high quality Bovine Serum Albumin, to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janis Wiener, MD 2368 Paysphere Cir, Chicago, IL 60674-2368 Ph: () - | Janis Wiener, MD 965 Lake St, Oak Park, IL 60301-1292 Ph: (708) 386-3000 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.
Haitian Prime Minister Jean-Max Bellerive "insisted Tuesday that progress is being made in his devastated homeland despite the trickle of international aid," the Miami Herald reports.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Lampire Biological Laboratories announced today that it signed an agreement with Proliant Health and Biologicals, manufacturer of the worlds most trusted, high quality Bovine Serum Albumin, to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
› Verified 5 days ago
Dr. Kristen Eileen Tobin Vealey, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1121 South Blvd, Oak Park, IL 60302 Phone: 708-745-5744 Fax: 708-398-6890 | |
Mr. Daniel B Stroupe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 S Maple Ave Ste 4050, Oak Park, IL 60304 Phone: 708-383-0943 Fax: 708-613-4382 | |
Dr. Ankur Sethi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7035 North Ave, Oak Park, IL 60302 Phone: 708-680-3800 | |
Dr. Terry Lynn Clarbour, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1033 Randolph St, Oak Park, IL 60302 Phone: 708-955-8033 Fax: 708-445-8444 | |
Paul Balter, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 855 Madison St, Oak Park, IL 60302 Phone: 708-386-1000 Fax: 708-386-2394 | |
Steve Michel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 965 Lake St, Oak Park, IL 60301 Phone: 708-386-3000 | |
Max L Harris, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Erie Ct, L700, Oak Park, IL 60302 Phone: 708-763-2536 Fax: 708-383-7655 |